stella
beta
MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease — Stella
Home
/
Autoimmune Liver Disease
/
MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
View on ClinicalTrials.gov
Recruiting
Back to Autoimmune Liver Disease trials
MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
Trial locations
(1 site)
United States
Cincinnati Children's Hospital and Medical Center, Cincinnati, Ohio